Get the Stockscreener App
194.55
1.62%
-3.21
After Hours:
194.55
Iqvia Holdings Inc stock is traded at $194.55, with a volume of 2.16M.
It is down -1.62% in the last 24 hours and up +23.55% over the past month.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
See More
Previous Close:
$197.76
Open:
$197.76
24h Volume:
2.16M
Relative Volume:
0.91
Market Cap:
$33.07B
Revenue:
$15.50B
Net Income/Loss:
$1.33B
P/E Ratio:
26.51
EPS:
7.34
Net Cash Flow:
$2.16B
1W Performance:
+3.83%
1M Performance:
+23.55%
6M Performance:
-1.78%
1Y Performance:
-18.00%
1-Day Range:
$192.17
$198.04
1-Week Range:
$192.17
$206.78
52-Week Range:
$134.65
$252.88
Iqvia Holdings Inc Stock (IQV) Company Profile
Name
Iqvia Holdings Inc
Sector
Industry
Phone
919-998-2000
Address
2400 ELLIS ROAD, DURHAM, NC
Compare IQV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
194.55 | 33.62B | 15.50B | 1.33B | 2.16B | 7.34 |
|
TMO
Thermo Fisher Scientific Inc
|
482.16 | 183.07B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
206.85 | 145.32B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
573.07 | 45.56B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
119.84 | 33.96B | 6.63B | 1.17B | 1.19B | 4.05 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-25-25 | Downgrade | HSBC Securities | Buy → Hold |
| Apr-10-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Feb-03-25 | Downgrade | BTIG Research | Buy → Neutral |
| Dec-20-24 | Initiated | Stephens | Overweight |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Sep-04-24 | Initiated | RBC Capital Mkts | Outperform |
| Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
| Jun-06-24 | Initiated | Goldman | Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-15-24 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-13-24 | Initiated | BTIG Research | Buy |
| Nov-02-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Mar-17-23 | Initiated | Truist | Buy |
| Dec-06-22 | Initiated | Cowen | Outperform |
| Nov-17-22 | Downgrade | Citigroup | Buy → Neutral |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-15-22 | Initiated | SVB Leerink | Outperform |
| May-24-22 | Initiated | Guggenheim | Buy |
| Apr-29-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Apr-16-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Mar-08-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jul-07-20 | Initiated | Stephens | Equal-Weight |
| Mar-02-20 | Initiated | Deutsche Bank | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Dec-13-19 | Upgrade | CFRA | Sell → Hold |
| Nov-14-19 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-21-19 | Upgrade | Mizuho | Neutral → Buy |
| May-28-19 | Initiated | SVB Leerink | Outperform |
| Jan-18-19 | Upgrade | Jefferies | Hold → Buy |
| Oct-09-18 | Initiated | UBS | Buy |
| Oct-02-18 | Reiterated | Robert W. Baird | Outperform |
| Jul-25-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-25-18 | Reiterated | Stifel | Buy |
| Jul-03-18 | Upgrade | Raymond James | Outperform → Strong Buy |
| Apr-13-18 | Upgrade | Goldman | Neutral → Buy |
| Mar-07-18 | Upgrade | SunTrust | Hold → Buy |
| Jan-19-18 | Initiated | Evercore ISI | Outperform |
View All
Iqvia Holdings Inc Stock (IQV) Latest News
Fiserv Q2 Earnings Beat Estimates on Strong Margins, Revenues Miss - The Globe and Mail
5 Revealing Analyst Questions From IQVIA’s Q2 Earnings Call - Yahoo.co
What is the risk reward ratio of investing in IQVIA Holdings Inc. stockEntry Signal Growth Plan For Every Investor - jammulinksnews.com
IQVIA’s SWOT analysis: healthcare giant faces mixed outlook amid industry shifts - Investing.com Australia
IQVIA (IQV) Reliance on International Sales: What Investors Need to Know - Yahoo Finance
How does IQVIA Holdings Inc. compare to its industry peersBuild a portfolio that stands the test of time - jammulinksnews.com
IQVIA Holdings Inc.'s (NYSE:IQV) P/E Is Still On The Mark Following 26% Share Price Bounce - 富途牛牛
IQVIA Holdings Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
What are analysts’ price targets for IQVIA Holdings Inc. in the next 12 monthsUnlock your portfolio’s hidden potential - jammulinksnews.com
What are the latest earnings results for IQVIA Holdings Inc.Capitalize on emerging investment opportunities - jammulinksnews.com
How strong is IQVIA Holdings Inc. company’s balance sheetExceptional market positioning - jammulinksnews.com
Why IQVIA Holdings Inc. stock attracts strong analyst attentionFree Access to Community - metal.it
What markets is IQVIA Holdings Inc. expanding into Is SGLY stock a good long term investment optionCapital growth strategies that work - jammulinksnews.com
Why is IQVIA Holdings Inc. stock attracting strong analyst attentionGet timely alerts on top-performing stocks - jammulinksnews.com
What makes IQVIA Holdings Inc. stock price move sharplyFree Stock Market Practical Discussion Forums - metal.it
What are the technical indicators suggesting about IQVIA Holdings Inc.Jaw-dropping returns - jammulinksnews.com
Thermo Fisher, Baker Hughes And IQVIA Holdings Are Among Top 10 Large Cap Gainers Last Week (July 21-July 25): Are The Others In Your Portfolio? - 富途牛牛
What catalysts could drive IQVIA Holdings Inc. stock higher in 2025Free Stock Market Query - jammulinksnews.com
How does IQVIA Holdings Inc. generate profit in a changing economyExceptional trading performance - jammulinksnews.com
Mizuho Raises IQVIA Holdings' Price Target to $225, Maintains "Outperform" Rating. - AInvest
The Undervalued Potential of IQVIA Holdings: A DCF and Market Fundamentals Analysis - AInvest
Is There An Opportunity With IQVIA Holdings Inc.'s (NYSE:IQV) 39% Undervaluation? - Yahoo Finance
IQVIA Holdings (IQV): Mizuho Raises Price Target to $225 | IQV S - GuruFocus
IQVIA Hldgs Stock Price, Quotes and Forecasts | NYSE:IQV - Benzinga
What analysts say about IQVIA Holdings Inc. stockOverwhelming profit margins - PrintWeekIndia
Iqvia price target raised to $225 from $190 at Mizuho - TipRanks
How IQVIA Holdings Inc. stock reacts to Fed policy changesHigh-yield capital appreciation - jammulinksnews.com
IQVIA Holdings Inc. Stock Analysis and ForecastFree Investment Risk Control - PrintWeekIndia
IQV Stock Target Price Raised to $225 by Mizuho Analyst | IQV St - GuruFocus
What makes IQVIA Holdings Inc. stock attractive to long term investorsTremendous growth opportunities - jammulinksnews.com
IQVIA's Trading Volume Hits 11.03 Billion, Ranks 81st in Market as Stock Surges 3.39% - AInvest
IQVIA Holdings (IQV) Receives a Hold from Jefferies - The Globe and Mail
A Quick Look at Today's Ratings for IQVIA Holdings(IQV.US), With a Forecast Between $195 to $235 - 富途牛牛
IQVIA Holdings (IQV) Snaps 2-Day Losses on Higher-than-Expected Earnings - MSN
Citi Sticks to Their Hold Rating for IQVIA Holdings (IQV) - The Globe and Mail
Earnings Tell The Story For IQVIA Holdings Inc. (NYSE:IQV) As Its Stock Soars 25% - simplywall.st
IQVIA Holdings Reports Strong Q2 2025 Results - The Globe and Mail
IQVIA Holdings Reports Record Revenue Amid Challenges - The Globe and Mail
IQV: UBS Raises Price Target on IQVIA Holdings to $225 | IQV Stock News - GuruFocus
Iqvia (IQV) Receives Target Price Boost from Evercore ISI | IQV Stock News - GuruFocus
Why IQVIA (IQV) Stock Is Up Today - Yahoo Finance
TD Cowen raises IQVIA stock price target to $206 on stabilizing market - Investing.com Canada
IQVIA Holdings (IQV): Truist Securities Raises Price Target | IQV Stock News - GuruFocus
IQVIA Holdings (IQV): Truist Securities Raises Price Target | IQ - GuruFocus
IQV: UBS Analyst Increases Price Target and Maintains Buy Rating - GuruFocus
What drives IQVIA Holdings Inc. stock priceRapid-fire capital growth - jammulinksnews.com
IQV: Baird Maintains Neutral Rating, Raises Price Target to $196 - GuruFocus
Iqvia (IQV) Price Target Boosted by Truist Analyst | IQV Stock N - GuruFocus
IQVIA Holdings Inc. (NYSE:IQV) Q2 2025 Earnings Call Transcript - MSN
Baird Adjusts Price Target for Iqvia (IQV) to $196 Following Q2 Results | IQV Stock News - GuruFocus
Is IQVIA Holdings Inc. a good long term investmentHigh-yield growth strategies - Autocar Professional
Iqvia Holdings Inc Stock (IQV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.25%
0.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):